Gaingels

VerImmune, based in Baltimore, Maryland, is an immuno-oncology company focused on developing innovative cancer therapies through a unique approach called Anti-tumor Immune Redirection. The company employs proprietary virus-inspired particles, known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs), which harness pre-existing immune memory from past infections or childhood vaccinations to target tumors. This strategy aims to offer a new treatment option for patients with limited alternatives or those who have developed resistance to conventional cancer therapies. VerImmune's technology seeks to deliver low toxicity and sustainable benefits across a wide array of cancers, potentially reshaping the treatment landscape for difficult-to-treat cases.

cloudtamer.io is comprehensive cloud governance software that allows you to manage your cloud presence at scale. With cloudtamer.io, your team can easily request and manage cloud resources that are aligned with your budget, security, and compliance policies.

Sonavi Labs, Inc. is a medical device and software company based in Baltimore, Maryland, established in 2017. The company specializes in developing advanced medical products that utilize artificial intelligence to analyze body sounds for disease diagnosis. By focusing on innovative technologies, Sonavi Labs aims to improve patient experiences and enhance the diagnostic capabilities of healthcare providers.

Protenus, Inc. is a Baltimore-based company that specializes in a healthcare compliance analytics platform designed to protect patient privacy and secure health data. Utilizing artificial intelligence, the platform audits every access to patient records across leading health systems in the United States. It enables healthcare organizations to gain comprehensive insights into the usage of health data, proactively identifying risks such as inappropriate access to patient information and potential theft or misuse of controlled substances by staff. By alerting compliance teams to policy violations and other anomalous behaviors, Protenus empowers hospitals to make informed decisions to enhance data protection and safeguard their institutions. The company, which was established in 2014 and previously known as Protenus, LLC, focuses on reducing risk and optimizing operational efficiency for its partner hospitals.

Super Home Inc. offers a subscription-based service designed to assist homeowners with care and repair for their properties. Founded in 2014 and headquartered in San Francisco, California, the company serves members in Washington, DC, and Maryland. Super provides coverage for repairs and replacements of appliances and home systems that experience breakdowns. Users can conveniently access services through various devices, including desktop and mobile platforms. Additionally, Super's maintenance schedule helps homeowners understand their property's needs, ensuring they receive timely assistance without incurring high costs.

Communication between general contractors and their vendors on construction projects is complex and fragmented, yet it’s mostly handled through email. Naturally, critical items get lost in personal inbox clutter. As a result, everyone suffers the financial impacts of project delays, disputes, and issues. TargetDocs bridges the gap between general contractors and vendors by connecting them through one communication workspace, so items never fall through the cracks and project teams are always on the same page. Learn more at www.targetdocs.com

American Gene Technologies is a gene and cell therapeutics company based in Rockville, Maryland, founded in 2007. The company specializes in developing a proprietary lentiviral platform that enables the creation of bio-safe lentivirus therapies for a range of applications, including cancer, HIV/AIDS, and inherited disorders. Their developmental portfolio features advanced tools and components for gene therapy and regenerative medicine, with a focus on innovative treatments like AGT103-T, which aims to provide a functional cure for HIV. Additionally, American Gene Technologies is working on a synthetic gene designed to deliver therapeutic levels of phenylalanine hydroxylase for the treatment of Phenylketonuria (PKU). The company's mission is to harness gene and cell therapy to alleviate suffering from serious diseases.

Developer of a data quality surveillance platform designed to monitor and actively defend against data pipeline corruption. The company's technology includes a data firewall that captures erroneous data at the source and prevents it from entering downstream data platforms and combines it with data pipelines, data flows and surveillance hub as well as uses machine learning to automatically create data rules and adapt those rules through supervised workflows, enabling firms to detect and respond to anomalies in real-time with active measures such as a message-level quarantining.

Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal cancers and related diseases. Established in 2018 and based in Halethorpe, Maryland, the company specializes in diagnosing esophageal cancer and its precancerous condition, Barrett’s esophagus. By leveraging advancements in diagnostics and medical technology, Capsulomics aims to improve early detection and intervention for gastrointestinal cancers, contributing to better patient outcomes.

Hungry Marketplace, Inc. operates a mobile food marketplace that connects food enthusiasts with local chefs, providing a platform for ordering made-to-order meals. Founded in 2016 and based in Arlington, Virginia, the company delivers fresh-cooked meals across the District of Columbia, Maryland, and Virginia. Hungry specializes in catering by offering a diverse selection of curated menus from independent chefs, primarily serving businesses seeking quality office lunches. The company has successfully raised significant funding, with a notable Series B round led by prominent investors, enhancing its ability to expand its services. Committed to community welfare, Hungry's "Fight Against Hunger" initiative donates one meal to those in need for every two meals purchased, while its "WeRecycle" program emphasizes environmental sustainability through the use of biodegradable utensils. With plans for rapid expansion into additional U.S. cities, Hungry aims to become a significant player in the $60 billion catering market.

Sonavi Labs, Inc. is a medical device and software company based in Baltimore, Maryland, established in 2017. The company specializes in developing advanced medical products that utilize artificial intelligence to analyze body sounds for disease diagnosis. By focusing on innovative technologies, Sonavi Labs aims to improve patient experiences and enhance the diagnostic capabilities of healthcare providers.

Sonavex, Inc. is a Baltimore-based company founded in 2013 that specializes in advanced imaging technology for surgical patients. The company's primary focus is on developing an ultrasound-based method to detect anastomotic blood clots, which are critical for patient recovery post-surgery. By providing clinicians with real-time visualization of essential data directly at the point of care, Sonavex aims to enhance clinical decision-making and improve patient outcomes. Their proprietary technology platform allows for the measurement of crucial intravascular flow metrics, enabling the early detection of post-operative clots and contributing to better overall surgical results.

American Gene Technologies is a gene and cell therapeutics company based in Rockville, Maryland, founded in 2007. The company specializes in developing a proprietary lentiviral platform that enables the creation of bio-safe lentivirus therapies for a range of applications, including cancer, HIV/AIDS, and inherited disorders. Their developmental portfolio features advanced tools and components for gene therapy and regenerative medicine, with a focus on innovative treatments like AGT103-T, which aims to provide a functional cure for HIV. Additionally, American Gene Technologies is working on a synthetic gene designed to deliver therapeutic levels of phenylalanine hydroxylase for the treatment of Phenylketonuria (PKU). The company's mission is to harness gene and cell therapy to alleviate suffering from serious diseases.

Vixiar Medical, Inc., founded in 2013 and located in Annapolis, Maryland, specializes in developing non-invasive and cost-effective medical devices for monitoring cardiopulmonary diseases. The company's flagship product, Indicor, is a handheld point-of-care device that enables healthcare professionals to monitor worsening heart failure. Vixiar's devices are designed to assess cardiac filling pressure in various settings, including homes, physician's offices, nursing homes, and hospitals. By focusing on improving clinical workflow and delivering economic value, Vixiar aims to address the significant clinical and economic burdens associated with cardiopulmonary conditions.

Scene Health is a mobile health company that focuses on improving patient engagement and medication adherence through innovative technology. Utilizing a smartphone application, patients can video record themselves taking their medication, which allows healthcare providers to assess adherence and interact with patients via a secure web portal. The platform is designed to support various healthcare sectors, including public health departments, clinical trials, hospitals, and managed care organizations, particularly for patients with conditions such as tuberculosis, opioid use disorder, hepatitis C, and diabetes. Scene Health offers customizable reporting to care teams, providing insights from daily video submissions to enhance patient care. The platform is multilingual, functions offline, and has been shown in an NIH-funded study by Johns Hopkins to achieve an average medication adherence rate of 94 percent among participants. Founded in 2008 and based in Baltimore, Maryland, Scene Health continues to advance its mission of empowering patients through technology.